Literature DB >> 22203543

Prostate cancer screening--the evidence, the recommendations, and the clinical implications.

Roger Chou1, Michael L LeFevre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22203543     DOI： 10.1001/jama.2011.1891

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

1.  [Recommendations against prostate cancer screening with PSA].

Authors:  Mercè Marzo-Castillejo; María Ángeles Nuin-Villanueva; Carmen Vela-Vallespín
Journal:  Aten Primaria       Date:  2012-04-18       Impact factor: 1.137

2.  Expected population impacts of discontinued prostate-specific antigen screening.

Authors:  Roman Gulati; Alex Tsodikov; Ruth Etzioni; Rachel A Hunter-Merrill; John L Gore; Angela B Mariotto; Matthew R Cooperberg
Journal:  Cancer       Date:  2014-07-25       Impact factor: 6.860

3.  Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.

Authors:  Joshua A Roth; Roman Gulati; John L Gore; Matthew R Cooperberg; Ruth Etzioni
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

Review 4.  Urinary biomarkers for prostate cancer.

Authors:  John T Wei
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

5.  Risk perception and psychological morbidity in men at elevated risk for prostate cancer.

Authors:  A G Matthew; T Davidson; S Ochs; K L Currie; A Petrella; A Finelli
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

6.  National evidence on the use of shared decision making in prostate-specific antigen screening.

Authors:  Paul K J Han; Sarah Kobrin; Nancy Breen; Djenaba A Joseph; Jun Li; Dominick L Frosch; Carrie N Klabunde
Journal:  Ann Fam Med       Date:  2013 Jul-Aug       Impact factor: 5.166

Review 7.  Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.

Authors:  Todd Morgan; Ganesh Palapattu; John Wei
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

Review 8.  The biology of castration-resistant prostate cancer.

Authors:  Fei Lian; Nitya V Sharma; Josue D Moran; Carlos S Moreno
Journal:  Curr Probl Cancer       Date:  2014-11-25       Impact factor: 3.187

9.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

Review 10.  Does robotic prostatectomy meet its promise in the management of prostate cancer?

Authors:  Kuo-How Huang; Stacey C Carter; Jim C Hu
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.